Children's Hospital of Fudan University
Shanghai, China
NCT Number: NCT04537364
To establish the prediction of the renal damage and renal development deficiency in congenital anomalies of kidney and urinary tract (CAKUT), a diagnostic accuracy study on MRI-DWI combined with urinary microprotein detection is to carried out comparing with DMSA scan as the golden standard for renal damage.
Looking for future studies?
Notify Me1 day–18 year
All sexes
Observational
Shanghai, China
Congenital anomalies of kidney and urinary tract (CAKUT) is one of the common birth defects, with a morbidity of 6‰. The delayed diagnosis, due to its demanding diagnostic technique, may leads to long-term severe renal damage. This project is a prospective, continuous double-blind designed diagnostic accuracy study. The clinical diagnosis of CAKUT relies on a panel of radiological examinations most of which are invasive and risk of radiation harm for children. To establish the non-invasive and safe diagnosis detections of renal damage of CAKUT in children, a combination of MRI/DWI with urinary detection through Immunomagnetic beads isolation technique is to carried out to evaluate the renal deficiency in CAKUT comparing the dimercaptosuccinic acid (DMSA) scan as the golden standard of renal parenchymal damage. Analysis of sensitivity and specificity is to evaluate the accuracy of the combined diagnostic protocol. Furthermore the clinical information of pregnancy and phenotypes of the patients with CAKUT is to be collected with all the genetic information constructing the full phenotype- genotype spectrum for big data analysis and predictive model for early detection of renal damage in CAKUT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patient that was diagnosed clinically and genetically as:
Exclusion criteria
This study is an observational study to evaluate the accuracy of renal parenchymal damage combined diagnosis with no intervention. All patients from the cohort accept MRI-DWI scan,the urinary biomarkers detection, disease gene detection and DMSA scan.
MRI-DWI: All the scans are performed using the MagnetomVerio 3.0T magnetic resonance imaging system from Siemens.
Urinary polypeptide collection: Urine samples requirements: volume between 50-100ml, specific gravity >1.010. Immunomagnetic beads isolation technique is used to collect polypeptide.
Time frame: Within 3 months since diagnosis of CAKUT.
The accuracy of combined diagnosis includes sensitivity and specificity. The reference standard test (DMSA scan) and combined diagnosis are conducted in the cohort of pediatric children diagnosed of CAKUT.
Sensitivity is defined as: The proportion of renal parenchymal damage is successfully screened out by combined diagnosis.
Specificity is defined as: The proportion of children without renal parenchymal damage who are not recognized as impairment by combined diagnosis.
Children's Hospital of Fudan University
Other
Protocol for a Cohort Diagnostic Accuracy Study to Develop Prediction of Renal Parenchymal Damage and to Evaluate Accuracy of Renal Function in Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729566
CAKUT, Cakut
Sohag, Sohag Governorate, Egypt
View Trial DetailsNCT04115345
Cakut, Chronic Disease
Atlanta, Georgia, United States
View Trial DetailsNCT06921733
Cakut, Congenital Anomalies of Kidney and Urinary Tract
Erlangen, Bavaria, Germany
View Trial DetailsNCT06728007
Cakut, Congenital Abnormalities
Bologna, Italy
View Trial Details